94483-64-4

Usage

Uses

Used in Pharmaceutical Industry:
AMYL 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSIDE is used as a chemical intermediate for the synthesis of various drugs, leveraging its versatile chemical properties to facilitate the development of new medications.
Used in Antibacterial Applications:
AMYL 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSIDE is studied for its potential antibacterial properties, making it a candidate for the development of new antibiotics to combat bacterial infections.
Used in Antifungal Applications:
AMYL 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSIDE is also investigated for its potential antifungal properties, indicating its use in the development of antifungal medications to treat fungal infections.
Used in Cancer Treatment Research:
AMYL 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSIDE is explored for its potential use in the treatment of cancer, suggesting its application in oncology for developing novel therapeutic approaches.
Used in Diabetes Treatment Research:
AMYL 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSIDE is studied for its potential role in the treatment of diabetes, indicating its possible application in the development of medications for managing blood sugar levels and related complications.

Upstream product

• 71-41-0 pentan-1-ol 
• 3068-34-6 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-α-D-glucopyranosyl chloride 
• 146288-29-1 Pentyl 3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido-β-D-glucopyranoside 
• 10022-13-6 1,3,4,6-tetra-O-acetyl-2-deoxy-2-phthalimido-β-D-glucopyranose 
• 146288-30-4 pentyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-β-D-glucopyranoside 

Relevant academic research and scientific papers

Convergent synthesis of tetra- and penta-saccharide fragments of dimeric Lewis X

The convergent synthesis of tetra- and penta-saccharide fragments of the TACA dimeric Lex is described. The synthetic strategy relied on the preparation of a protected GlcNTCA-(1,3)-Gal-(1,4)-GlcNAc trisaccharide diol free at O-3 of both glucos

N-ACETYLGLUCOSAMINE DERIVATIVES AND USE THEREOF

The present invention relates to An N-acetylglucosamine derivative represented by the following formula (1), and a hyaluronic acid production promoting agent containing the same and a skin external preparation containing the same: wherein R1 is a hydrogen atom or an alkyl group having 2 to 18 carbon atoms; R2, R3, and R4 are hydrogen atoms or acyl groups having 2 to 18 carbon atoms and may be all the same or different from others; the steric structure at position 1 may be α or β; provided that R1, R2, R3, and R4 must not be all hydrogen atoms. It is intended to provide an easily available hyaluronic acid production promoting agent and a skin external preparation whereby the production of hyaluronic acid can be promoted in the skin and thus the skin can be maintained in a vital and moist state so that it is expected that the human skin can be prevented from age.

A spacer-modified disaccharide as a photoaffinity reagent for the acceptor-binding area of bovine (1->4)-β-D-galactosyltransferase: comparison of its acceptor properties with those of other 2-acetamido-2-deoxy-β-D-glucopyranosides

The spacer-modified disaccharide 1,10-di-O-(2-acetamido-2-deoxy-β-D-glucopyranosyl)-2-azi-1,10-decanediol (10) that mimics the biantennary core heptasaccharide of N-glycoproteins has been synthesised.Compound 10 is an excellent acceptor in galactosyltransferase-catalysed galactosylation by UDP-galactose, is superior (7-8 fold) to analogues that have only one GlcNAc unit, and is an efficient photoaffinity reagent for galactosyltransferase.In the presence of UDP-Gal, no photoaffinity labelling by 10 takes place, which agrees with the mechanism of galactosyltransferase action.